ALC Stock Recent News

Investors continue to be optimistic about Alcon (ALC), backed by a competitive product portfolio and strong commercial execution.

Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Alcon (ALC) continues gaining from the company's diverse portfolio, incremental innovation, and new product launches.

Within Vision Care, Alcon (ALC) is registering solid growth, banking on strong sales of its contact lenses and ocular health products.

Here is how Alcon (ALC) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Alcon (ALC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank like ALC, RDY and ANIK, as these will be less volatile than the broader market.

Here is how Alcon (ALC) and Molina (MOH) have performed compared to their sector so far this year.

Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.